Orsense - Non-Invasive Technologues

Please choose your location:

Orsense - non-invasive technologies

News & Events > Press Releases

NBM200 receives Anvisa clearance Orsense delivers first systems in Brazil

Jul. 15, 2014

Petach Tikva, Israel, July 15, 2014 – OrSense Ltd., developer of solutions for non-invasive measurements of hemoglobin, today announces a first delivery of its NBM200 non-invasive Hemoglobin testing systems in Brazil.

The delivery of systems follows the recent approval of the NBM200 by Anvisa, the Brazilian Health Surveillance Agency. The NBM200 systems will be distributed and serviced in Brazil by Fujicom, a national distributor of medical equipment and supplies to hospitals and blood banks.

Non invasive Hemoglobin testing uses optical measurement to replace traditional invasive blood testing. The NBM200 offers accurate, painless, Hb measurements on location. The non-invasive test further reduces infection risk as no blood is drawn, and with no consumables such as lancets, gloves etc. and no need for hazardous waste handling the system is also environmentally friendly.

Commented Yoav Reisman, CEO of Orsense: “We are happy to add Brazil to the growing list of countries were the NBM 200 has now been cleared and being put to use, and Fujicom as a business partner”.  Edmar Fujita Jr CEO of Fujicom, Orense’s distributor in Brazil said “We have been preparing for the NBM200 launch for some time and now with the Anvisa approval in place expect to move ahead quickly to introduce the systems to our clients“

About OrSense 

OrSense is a medical device company developing and marketing non-invasive monitoring systems for measurement of Hemoglobin. OrSense’s systems are available and been successfully installed in dozens of blood donation facilities worldwide. OrSense's products are based on its proprietary Occlusion Spectroscopy technology. Investors in the Company include Israel Health Care Ventures, Saints Capital and LTG. For additional information, please visit OrSense’s website at www.orsense.com.

About Fujicom

Fujicom is a national distributor of medical equipment and supplies to hospitals and blood banks. Fujicom was established in 1998 and is part of the Fujita group. For additional information, please visit Fujicom’s website at www.fujicom.com.br

About OrSense's Technology

OrSense’s NBM200 is based on the company’s proprietary SpectOLightTM technology, which uses an optical measurement platform combined with a ring-shaped sensor that is fitted on the subject's finger.  A gentle pressure is applied by the sensor, temporarily occluding the blood flow in the finger. New blood dynamics are created, generating a unique, strong optical transmission signal, with a high signal-to-noise ratio which is wholly blood specific. During the occlusion, optical elements in the sensor perform a sensitive measurement of the light transmitted through the finger. This method, called Occlusion Spectroscopy, provides a quick, accurate and painless measurement of the subject's blood constituents.

* * *

Orsense Ltd. contact:
Mikael Flensburg
Chief Commercial Officer
OrSense Ltd.
Mobile: +46 (0) 760 477090
E-mail: mikael.flensburg@orsense.com

Press Releases Archive